Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $2686.0.

  • Tonix Pharmaceuticals Holding's Non-cash Items fell 9591.12% to $2686.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2686.0, marking a year-over-year decrease of 9591.12%. This contributed to the annual value of $936.0 for FY2024, which is 9964.0% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Non-cash Items stood at $2686.0 for Q3 2025, which was down 9591.12% from $2294.0 recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Non-cash Items' 5-year high stood at $892008.0 during Q1 2023, with a 5-year trough of $936.0 in Q4 2024.
  • Its 3-year average for Non-cash Items is $209743.9, with a median of $65691.0 in 2024.
  • In the last 5 years, Tonix Pharmaceuticals Holding's Non-cash Items crashed by 3572.92% in 2024 and then tumbled by 9968.88% in 2025.
  • Tonix Pharmaceuticals Holding's Non-cash Items (Quarter) stood at $259991.0 in 2023, then tumbled by 99.64% to $936.0 in 2024, then soared by 186.97% to $2686.0 in 2025.
  • Its last three reported values are $2686.0 in Q3 2025, $2294.0 for Q2 2025, and $1784.0 during Q1 2025.